Sarissa Capital Management as of June 30, 2017
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 8 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biogen Idec (BIIB) | 34.8 | $104M | 384k | 271.36 | |
| Bioverativ | 23.4 | $70M | 1.2M | 60.17 | |
| Medicines Company | 22.2 | $67M | 1.8M | 38.01 | |
| Innoviva (INVA) | 14.9 | $45M | 3.5M | 12.80 | |
| Noveliontherapeuti.. | 3.2 | $9.5M | 1.0M | 9.23 | |
| Advaxis | 0.7 | $2.2M | 339k | 6.49 | |
| Apricus Biosciences | 0.6 | $1.6M | 1.4M | 1.13 | |
| Abbvie (ABBV) | 0.2 | $725k | 10k | 72.50 |
